A Phase 3, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Individuals With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
A Phase 3, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Individuals With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
The purpose of this study is to evaluate the efficacy and safety of adjunctive KarXT for the treatment of mania in participants with Bipolar-I Disorder.
Inclusion Criteria:
Exclusion Criteria:
Clinical.Trials@bms.com855-907-3286
Bentonville, Arkansas 72712, United States
479-367-2688
ABB, Buenos Aires F.D. C1199ABB, Argentina
Pleven, 5800, Bulgaria
Ramat Gan, Central District 5265601, Israel
0585950299
Kitakyushu-shi, Fukuoka 8078555, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
+81-(0)3-3813-3111
Bunkyo-ku, Tokyo 1138603, Japan
+81-3-3822-2131
Sanpetru /Brasov, 507190, Romania
0040724993329
Skarzhyntsi, Khmelnytskyi Oblast 32120, Ukraine
501-350-3285
562-249-6956
909-488-9116
424-227-8127
562-690-2200
909-590-8409
714-289-1100
951-300-4924
305-669-6166
786-831-7303
912-744-0800
312-865-6336
314-771-6387
917-701-7484
512-323-2622
817-907-7330
214-396-4844
359892444643
+359888227165
0255035982
+390577585409
0562971361
+81-11-771-5660
0955770711
0339391191
+81-92-811-1821
+81-88-837-3000
+48600-107-410
+48503642588
602305132
+40721243869
0040723671301
0040757243543
0040745974029
+40749156565